Funding and Research Opportunities

The following funding opportunity announcements from the NHLBI or other components of the National Institutes of Health, might be of interest:

Notices

Findings of Research Misconduct
(NOT-OD-18-216) National Institutes of Health

Request for Information (RFI): Registration and Results Reporting Standards for Prospective Basic Science Studies Involving Human Participants
(NOT-OD-18-217) National Institutes of Health

Notice of NIBIB's Participation in NOT-TR-18-027 "Notice of Availability of Administrative Supplements for Tissue Chip Consortium Awardees: Development of Tissue Chips to Model Nociception, Opioid Addiction and Overdose"
(NOT-EB-18-023)
National Institute of Biomedical Imaging and Bioengineering

Notice to Clarify Eligibility Requirements of Program Directors/Principal Investigators (PDs/PIs) in PAR-16-439 "Support of Competitive Research (SCORE) Research Enhancement Award (SC1)"
(NOT-GM-18-043)
National Institute of General Medical Sciences

Notice to Clarify Eligibility Requirements of Program Directors/Principal Investigators (PDs/PIs) in PAR-16-438 "Support of Competitive Research (SCORE) Pilot Project Award (SC2)"
(NOT-GM-18-044)
National Institute of General Medical Sciences

Notice of NHLBI Participation in PA-18-592 "Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed)"
(NOT-HL-18-647)
National Heart, Lung, and Blood Institute

Requests for Applications

Clinical Trial on Effects of Statins in Older Adults without Clinical Cardiovascular Disease (U19 Clinical Trial Required)
(RFA-AG-19-020)
National Heart, Lung, and Blood Institute

Limited competition: Data Management and Resource Repository (DMRR) on Extracellular RNA (U54 Clinical Trial Not Allowed)
(RFA-RM-18-026)
Office of Strategic Coordination (Common Fund)

Advancing Extracellular RNA (exRNA) Communication Research: Improved Isolation and Analysis of exRNA-Carrier Subclasses (UG3/UH3 Clinical Trial Not Allowed)
(RFA-RM-18-027)
Office of Strategic Coordination (Common Fund)

Advancing Extracellular RNA (exRNA) Communication Research: Towards Single Extracellular Vesicle (EV) Sorting, Isolation, and Analysis of Cargo (UG3/UH3 Clinical Trial Not Allowed)
(RFA-RM-18-028)
Office of Strategic Coordination (Common Fund)

Novel and Innovative Tools to Facilitate Identification, Tracking, Manipulation, and Analysis of Glycans and their Functions (U01 Clinical Trial Not Allowed)
(RFA-RM-18-036)
Office of Strategic Coordination (Common Fund)

Innovative Adaptations to Simplify Existing Technologies for Manipulation and Analysis of Glycans (U01 Clinical Trial Not Allowed)
(RFA-RM-18-037)
Office of Strategic Coordination (Common Fund)